These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Substance abuse and psychosis. Goerke D; Kumra S Child Adolesc Psychiatr Clin N Am; 2013 Oct; 22(4):643-54. PubMed ID: 24012078 [TBL] [Abstract][Full Text] [Related]
6. Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness? Dalmau A; Bergman B; Brismar B Eur Psychiatry; 1999 Nov; 14(7):366-71. PubMed ID: 10683620 [TBL] [Abstract][Full Text] [Related]
7. Supersensitivity psychosis in a case with clozapine tolerance. Ozcan S; Soydan A; Tamam L Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():70-3. PubMed ID: 23090814 [TBL] [Abstract][Full Text] [Related]
8. Substance-induced psychoses: a critical review of the literature. Fiorentini A; Volonteri LS; Dragogna F; Rovera C; Maffini M; Mauri MC; Altamura CA Curr Drug Abuse Rev; 2011 Dec; 4(4):228-40. PubMed ID: 21999698 [TBL] [Abstract][Full Text] [Related]
9. Steroid-induced psychosis treated with risperidone. DeSilva CC; Nurse MC; Vokey K Can J Psychiatry; 2002 May; 47(4):388-9. PubMed ID: 12025444 [No Abstract] [Full Text] [Related]
10. [Psychiatric disorders induced by drug dependence other than alcohol]. Lejoyeux M; Mourad I; Ades J Encephale; 2000; 26(2):21-7. PubMed ID: 10858911 [TBL] [Abstract][Full Text] [Related]
11. Psychosis and synthetic cannabinoids. Deng H; Verrico CD; Kosten TR; Nielsen DA Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871 [TBL] [Abstract][Full Text] [Related]
12. Aripiprazole for treating cannabis-induced psychotic symptoms in ultrahigh-risk individuals. Rolland B; Geoffroy PA; Jardri R; Cottencin O Clin Neuropharmacol; 2013; 36(3):98-9. PubMed ID: 23673914 [TBL] [Abstract][Full Text] [Related]
13. Psychotic symptoms following buprenorphine withdrawal. Karila L; Berlin I; Benyamina A; Reynaud M Am J Psychiatry; 2008 Mar; 165(3):400-1. PubMed ID: 18316438 [No Abstract] [Full Text] [Related]
15. Treatment of refractory substance-induced psychosis in adolescent males with a genetic predisposition to mental illness. Rahmani M; Paul S; Nguyen ML Int J Adolesc Med Health; 2014; 26(2):297-301. PubMed ID: 24762642 [TBL] [Abstract][Full Text] [Related]
16. Pentobarbital for severe gamma-butyrolactone withdrawal. Sivilotti ML; Burns MJ; Aaron CK; Greenberg MJ Ann Emerg Med; 2001 Dec; 38(6):660-5. PubMed ID: 11719746 [TBL] [Abstract][Full Text] [Related]
17. [Acting out and psychoactive substances: alcohol, drugs, illicit substances]. Gillet C; Polard E; Mauduit N; Allain H Encephale; 2001; 27(4):351-9. PubMed ID: 11686057 [TBL] [Abstract][Full Text] [Related]
18. The phenomenology of the psychotic break and Huxley's trip: substance use and the onset of psychosis. Nelson B; Sass LA Psychopathology; 2008; 41(6):346-55. PubMed ID: 18765960 [TBL] [Abstract][Full Text] [Related]
20. Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse. Møller T; Linaker OM Nord J Psychiatry; 2004; 58(3):237-42. PubMed ID: 15204212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]